nach oben

AIDS and Behavior

Erschienen in:

01.04.2015 | Original Paper

Syndemic Vulnerability, Sexual and Injection Risk Behaviors, and HIV Continuum of Care Outcomes in HIV-Positive Injection Drug Users

verfasst von: Yuko Mizuno, David W. Purcell, Amy R. Knowlton, James D. Wilkinson, Marc N. Gourevitch, Kelly R. Knight

Erschienen in: AIDS and Behavior | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Limited investigations have been conducted on syndemics and HIV continuum of care outcomes. Using baseline data from a multi-site, randomized controlled study of HIV-positive injection drug users (n = 1,052), we examined whether psychosocial factors co-occurred, and whether these factors were additively associated with behavioral and HIV continuum of care outcomes. Experiencing one type of psychosocial problem was significantly (p < 0.05) associated with an increased odds of experiencing another type of problem. Persons with 3 or more psychosocial problems were significantly more likely to report sexual and injection risk behaviors and were less likely to be adherent to HIV medications. Persons with 4 or more problems were less likely to be virally suppressed. Reporting any problems was associated with not currently taking HIV medications. Our findings highlight the association of syndemics not only with risk behaviors, but also with outcomes related to the continuum of care for HIV-positive persons.

The White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States. July 2010. Washington DC: The White House. http://www.whitehouse.gov/administration/eop/onap/nhas. Accessed 23 Sept 2013.

Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med. 2011;365:493–505.CrossRefPubMedCentralPubMed

The White House. Executive Order: HIV care continuum initiative. July 2013. Washington DC: The White House. http://www.whitehouse.gov/the-press-office/2013/07/15/executive-order-hiv-care-continuum-initiative. Accessed 23 Sept 2013.

Hall HI, Frazier EL, Rhodes P, et al. Differences in human immunodeficiency virus care and treatment among subgroups in the United States. JAMA Intern Med. 2013;. doi:10.1001/jamainternmed.2013.6841.

Cohen SM, Van Handel MM, Branson BM, et al. Vital Signs: HIV prevention through care and treatment: United States. MMWR. 2011;2011(60):1618–23.

Centers for Disease Control and Prevention. HIV Surveillance: Epidemiology of HIV Infection (through 2011). 2013. http://www.cdc.gov/hiv/library/slideSets/index.html. Accessed 22 July 2014.

Avants SK, Warburton LA, Hawkins KA, Margolin A. Continuation of high-risk behavior by HIV-positive drug users: treatment implications. J Subst Abuse Treat. 2000;19:15–22.CrossRefPubMed

Kwiatkowski CF, Booth R. HIV-seropositive drug users and unprotected sex. AIDS Behav. 1998;2:151–60.CrossRef

Knight KR, Shade SB, Purcell DW, et al. Sexual transmission risk behavior reported among behaviorally bisexual HIV-seropositive injection drug using men. J AIDS. 2007;46(Supplement 2):S80–7.

10.

Latka MH, Metsch LR, Mizuno Y, et al. Unprotected sex among HIV-positive injection drug using women and their serodiscordant male partners: role of personal and partner influences. J AIDS. 2006;42:222–8.

11.

Latkin CA, Buchanan AS, Metsch LR, et al. Predictors of sharing injection equipment by HIV-seropositive injection drug users. J AIDS. 2008;49:447–50.

12.

Metsch LR, McCoy CB, Lai S, Miles C. Continuing risk behaviors among HIV-seropositive chronic drug users in Miami, Florida. AIDS Behav. 1998;2:161–9.CrossRef

13.

Meader N, Semaan S, Halton M, et al. An international systematic review and meta-analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs. AIDS Behav. 2013;17:1963–78.CrossRefPubMed

14.

Purcell DW, Mizuno Y, Metsch LR, et al. Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: associations by partner type and partner serostatus. J Urban Health. 2006;83:656–68.CrossRefPubMedCentralPubMed

15.

Krusi A, Evan W, Julio M, Thomas K. Social and structural determinants of HAART access and adherence among injection drug users. Int J Drug Policy. 2010;21:4–9.CrossRefPubMed

16.

Mizuno Y, Purcell DW, Borkowski TM, Knight K. The life priorities of HIV-seropositive injection drug users: findings from a community-based sample. AIDS Behav. 2003;7:395–403.CrossRefPubMed

17.

Singer M. AIDS and the health crisis of the US urban poor; The perspective of critical medical anthropology. Soc Sci Med. 1994;39:931–48.CrossRefPubMed

18.

Mustanski B, Garofalo R, Herrick A, Donenberg G. Psychological health problems increase risk for HIV among urban young men who have sex with men: preliminary evidence of a syndemic in need of attention. Ann Behav Med. 2007;34:37–45.CrossRefPubMedCentralPubMed

19.

Singer MC, Erickson PI, Badiane L, et al. Syndemics, sex, and the city: understanding sexually transmitted diseases in social and cultural context. Soc Sci Med. 2006;63:2010–21.CrossRefPubMed

20.

Dyer TP, Shoptaw S, Guadamuz TE, et al. Application of syndemic theory to black men who have sex with men in the Multicenter AIDS cohort study. J Urban Health. 2012;89:697–708.CrossRefPubMedCentralPubMed

21.

Halkitis PN, Moeller RW, Siconolfi DE, Storholm ED, Solomon TM, Bub KL. Measurement model exploring a syndemic in emerging adult gay and bisexual men. AIDS Behav. 2013;17:662–73.CrossRefPubMedCentralPubMed

22.

Jie W, Ciyong L, Xueqing D, Hui W, Lingyao H. A syndemic of psychosocial problems places the MSM population at greater risk of HIV infection. PLoS One. 2012;7:e32312.CrossRefPubMedCentralPubMed

23.

Parsons JT, Grov C, Golub SA. Sexual compulsivity, co-occuring psychosocial health problems, and HIV risk among gay and bisexual men: further evidence of a syndemic. AJPH. 2012;102:156–62.CrossRef

24.

Stall R, Mills T, Williamson J, Hart T, et al. Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. AJPH. 2003;93:939–42.CrossRef

25.

Brennan J, Kuhns LM, Johnson AK, Belzer M, Wilson EC, Garofalo R, the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Syndemic theory and HIV-related risk among young transgender women: the role of multiple, co-occurring health problems and social marginalization. AJPH. 2012;102:1751–7.CrossRef

26.

Senn TE, Carey MP, Vanable PA. The intersection of violence, substance use, depression, and STDs: testing of a syndemic pattern among patients attending an urban STD clinic. J Natl Med Assoc. 2010;102:614–20.PubMedCentralPubMed

27.

Pitpitan EV, Kalichman SC, Eaton LA, et al. Co-occurring psychosocial problems and HIV risk among women attending drinking venues in a South African township: a syndemic approach. Ann Behav Med. 2013;45:153–62.CrossRefPubMedCentralPubMed

28.

Gonsalez-Guarcia RM, McCabe BE, Florom-Smith A, Cianelli R, Peragallo N. Substance abuse, violence, HIV, and depression: an underlying syndemic factor among Latinas. Nurs Res. 2011;60:182–9.CrossRef

29.

Kurtz SP, Buttram ME, Surratt HL, Stall RD. Resilience, syndemic factors, and serosorting behaviors among HIV-positive and HIV-negative substance-using MSM. AIDS Educ Prev. 2012;24:193–205.CrossRefPubMedCentralPubMed

30.

Operario D, Nemoto T. HIV in transgender communities: syndemic dynamics and a need for multicomponent interventions. J AIDS. 2013;55(Supplement 2):S91–3.

31.

Knight KR, Purcell D, Dawson-Rose C, Gómez CA, Halkitis PN, The SUDIS Team. Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention. AIDS Educ Prev. 2005;17(1 Supplement A):76–88.CrossRefPubMed

32.

Anema A, Wood E, Weiser SD, Qi J, Montaner JS, Kerr T. Hunger and associated harms among injection drug users in an urban Canadian setting. Subst Abuse Treat Prev Policy. 2010;5:20.CrossRefPubMedCentralPubMed

33.

Mateu-Gelabert P, Maslow C, Flom PL, Sandoval M, Bolyard M, Friedman SR. Keeping it together: stigma, response, and perception of risk in relationships between drug injectors and crack smokers, and other community residents. AIDS Care. 2005;17:802–13.CrossRefPubMed

34.

Mitchell SG, Edwards LV, Mackenzie S, et al. Participants’ description of social support within a multisite intervention for HIV-seropositive injection drug users (INSPIRE). J AIDS. 2007;46(Supplement 2):S55–63.

35.

Friedman SR, Sandoval M, Mateu-Gelabert P, Meylakhs P, Des Jarlais DC. Symbiotic goals and the prevention of blood-borne viruses among injection drug users. Subst Use Misuse. 2011;46:307–515.CrossRefPubMedCentralPubMed

36.

Centers for Disease Control and Prevention. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: Summary guidance from CDC and US Department of Health and Human Services. MMWR. 2012;61(rr05):1–40.

37.

Milloy M-J, Kerr T, Buxton J, et al. Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy. J AIDS. 2012;59:393–9.

38.

Milloy M-J, Wood E, Small W, et al. Incarceration experiences in a cohort of active injection drug users. Drug Alcohol Rev. 2008;27:693–9.CrossRefPubMed

39.

Kittikraisak W, Davidson PJ, Hahn JA, et al. Incarceration among young injectors in San Francisco associations with risk for hepatitis virus infection. J Subst Use. 2006;11:271–81.CrossRef

40.

Small W, Wood E, Betteridge G, Montaner J, Kerr T. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care. 2009;21:708–14.CrossRefPubMed

41.

Martikainen P, Bartley M, Lahelma E. Psychosocial determinants of health in social epidemiology. Int J Epidemiol. 2002;31:1091–3.CrossRefPubMed

42.

Purcell DW, Latka MH, Metsch LR, et al. Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J AIDS. 2007;46(Supplement 2):S35–47.

43.

Purcell DW, Metsch LR, Latka M, et al. Interventions for seropositive injectors-research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. J AIDS. 2004;1(37):S110–8.

44.

Derogatis LR, Spencer PM. The Brief Symptom Inventory (BSI): administration, scoring, and procedure manual. Baltimore, MD: Wiley; 1982.

45.

Barrera MA. A method for assessing social support networks in community survey research. Connections. 1980;1980(3):3–8.

46.

Arnsten JH, Li X, Mizuno Y, et al. Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users. J AIDS. 2007;46(Supplement 2):S64–71.

47.

Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injection drug users. Soc Sci Med. 2005;61:1026–44.CrossRefPubMed

48.

Ferlatte O, Hottes TS, Trussler T, Marchand R. Evidence of a syndemic among young Canadian gay and bisexual men: Uncovering the associations between anti-gay experiences, psychosocial issues, and HIV risk. AIDS Behav. 2014;18:1256–63.CrossRefPubMed

49.

Mizuno Y, Borkowf C, Millett GA, Bingham T, Ayala G, Stuve A. Homophobia and racism experienced by Latino men who have sex with men: Correlates of exposure and associations with HIV risk behaviors. AIDS Behav. 2012;16:724–35.CrossRefPubMed

50.

Mizuno Y, Borkowf CB, Ayala G, Carballo-Dieguez A, Millett GA. Correlates of sexual risk for HIV among US-born and foreign-born Latino men who have sex with men (MSM): an analysis from the Brothers y Hermanos Study. J Immigr Minor Health. 2013;. doi:10.1007/s10903-013-9894-5.

51.

Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Bethesda, MD: Department of Health and Human Services (DHHS); 2013 Feb 12. Various p. [937 references].

52.

Valdiserri RO, Forsyth AD, Yakovchenko V, Koh HK. Measuring what matters: Development of standard HIV core indicators across the U.S. Department of Health and Human Services. Public Health Rep. 2013;128:354–9.PubMedCentralPubMed

Titel: Syndemic Vulnerability, Sexual and Injection Risk Behaviors, and HIV Continuum of Care Outcomes in HIV-Positive Injection Drug Users
verfasst von: Yuko Mizuno
David W. Purcell
Amy R. Knowlton
James D. Wilkinson
Marc N. Gourevitch
Kelly R. Knight
Publikationsdatum: 01.04.2015
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 4/2015
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-014-0890-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Syndemic Vulnerability, Sexual and Injection Risk Behaviors, and HIV Continuum of Care Outcomes in HIV-Positive Injection Drug Users

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2015

Understanding Treatment Refusal Among Adults Presenting for HIV-Testing in Soweto, South Africa: A Qualitative Study

Factors Enhancing Utilization of and Adherence to Prevention of Mother-to-Child Transmission (PMTCT) Service in an Urban Setting in Kenya

Explaining Antiretroviral Therapy Adherence Success Among HIV-Infected Children in Rural Uganda: A Qualitative Study

Barriers and Facilitators to the Implementation of SPNS Interventions Designed to Engage and Retain HIV Positive Women of Color in Medical Care

Comparison of Pharmacy-Based Measures of Adherence to Antiretroviral Therapy as Predictors of Virological Failure

Previously Undiagnosed HIV Infections Identified Through Cluster Investigation, North Carolina, 2002–2007

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin